X Li, W Sun, X Ding, W Li, J Chen - Frontiers in Immunology, 2022 - frontiersin.org
Background The combination of immune checkpoint inhibitors (ICIs) and anti-angiogenic
agents has shown promising efficacy in unresectable hepatocellular carcinoma (HCC), but …